Comparing two ways to close the left atrial appendage
Part of Heart & circulation clinical trials.
This trial compares a simpler procedure to the standard one for closing the left atrial appendage in people with non-valvular atrial fibrillation. The goal is to see which approach works better for preventing strokes while lowering bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have atrial fibrillation (not caused by heart valve disease) and a high risk of stroke or bleeding, or you cannot take blood thinners
- You are willing to have a procedure to close the left atrial appendage
- Your doctor expects you to live at least one more year
- You do not have a blood clot in your left atrial appendage
- You do not have severe kidney, liver, or bleeding problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different imaging tests can help guide a procedure that closes off the left atrial appendage to reduce stroke risk. It may help doctors choose the safest approach during the procedure.
This trial compares two ways to close off a part of the heart called the left atrial appendage to help prevent stroke risk in people with atrial fibrillation. It may help choose which procedure is safest and works best for your situation.
This trial tests a left atrial appendage closure device for people with atrial fibrillation who need an alternative to long-term blood thinners. It aims to see if the procedure can be done safely with conscious sedation instead of general anesthesia.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This study looks at whether a lower-dose blood thinner works as well as the usual recommended anti-clot treatment after a procedure that closes off the heart’s left atrial appendage. It may help reduce bleeding risk while still preventing dangerous blood clots.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.